Nurix Therapeutics
NRIX
NRIX
172 hedge funds and large institutions have $1.53B invested in Nurix Therapeutics in 2024 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 66 increasing their positions, 58 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
3% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 29
4.18% less ownership
Funds ownership: 109.57% → 105.39% (-4.2%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
172
Holding in Top 10
3
Calls
$1.84M
Puts
$1.21M
Top Buyers
| 1 | +$37.1M | |
| 2 | +$13.8M | |
| 3 | +$12.7M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$12.4M |
| 5 |
NAMA
Nikko Asset Management Americas
New York
|
+$12.4M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$13.6M | |
| 3 | -$8.49M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.58M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$6.91M |